Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).
du Bois A, Quinn M, Thigpen T, Vermorken J, Avall-Lundqvist E, Bookman M, Bowtell D, Brady M, Casado A, Cervantes A, Eisenhauer E, Friedlaender M, Fujiwara K, Grenman S, Guastalla JP, Harper P, Hogberg T, Kaye S, Kitchener H, Kristensen G, Mannel R, Meier W, Miller B, Neijt JP, Oza A, Ozols R, Parmar M, Pecorelli S, Pfisterer J, Poveda A, Provencher D, Pujade-Lauraine E, Randall M, Rochon J, Rustin G, Sagae S, Stehman F, Stuart G, Trimble E, Vasey P, Vergote I, Verheijen R, Wagner U; Gynecologic Cancer Intergroup; AGO-OVAR; ANZGOG; EORTC; GEICO; GINECO; GOG; JGOG; MRC/NCRI; NCIC-CTG; NCI-US; NSGO; RTOG; SGCTG; IGCS; Organizational team of the two prior International OCCC. du Bois A, et al. Among authors: kaye s. Ann Oncol. 2005;16 Suppl 8:viii7-viii12. doi: 10.1093/annonc/mdi961. Ann Oncol. 2005. PMID: 16239238 Free article. No abstract available.
3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.
Stuart G, Avall-Lundqvist E, du Bois A, Bookman M, Bowtell D, Brady M, Casado A, Cervantes A, Eisenhauer E, Friedlaender M, Fujiwara K, Grenman S, Guastalla JP, Harper P, Hogberg T, Kaye S, Kitchener H, Kristensen G, Mannel R, Meier W, Miller B, Oza A, Ozols R, Parmar M, Pfisterer J, Poveda A, Provencher D, Pujade-Lauraine E, Quinn M, Randall M, Rochon J, Rustin G, Sagae S, Stehman F, Trimble E, Thigpen T, Vasey P, Vergote I, Verheijen R, Vermorken J, Wagner U; NCIC-CTG; NSGO; AGO-OVAR; GOG; ANZGOG; EORTC; GEICO; JGOG; GINECO; MRC/NCRI; SGCTG; RTOG; NCI-US. Stuart G, et al. Among authors: kaye s. Ann Oncol. 2005;16 Suppl 8:viii36-viii38. doi: 10.1093/annonc/mdi965. Ann Oncol. 2005. PMID: 16239235 Free article. No abstract available.
Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens.
Thigpen T, Stuart G, du Bois A, Friedlander M, Fujiwara K, Guastalla JP, Kaye S, Kitchener H, Kristensen G, Mannel R, Meier W, Miller B, Poveda A, Provencher D, Stehman F, Vergote I; Gynecologic Cancer Intergroup; GOG; NCIC-CTG; AGO-OVAR; ANZGOG; JGOG; GINECO; SGCTG; MRC/NCRI; NSGO; RTOG; GEICO; EORTC. Thigpen T, et al. Among authors: kaye s. Ann Oncol. 2005;16 Suppl 8:viii13-viii19. doi: 10.1093/annonc/mdi962. Ann Oncol. 2005. PMID: 16239232 Free article. No abstract available.
Advanced ovarian cancer. Carboplatin versus cisplatin.
Vermorken JB, ten Bokkel Huinink WW, Eisenhauer EA, Favalli G, Belpomme D, Conte PF, Kaye SB. Vermorken JB, et al. Among authors: kaye sb. Ann Oncol. 1993;4 Suppl 4:41-8. Ann Oncol. 1993. PMID: 8312200 Review.
New non-cytotoxic approaches to ovarian cancer.
Kaye SB, Eisenhauer EA, Hamilton TC. Kaye SB, et al. Ann Oncol. 1999;10 Suppl 1:65-8. doi: 10.1023/a:1008315603401. Ann Oncol. 1999. PMID: 10219456 Review.
Intergroup collaboration in ovarian cancer: a giant step forward.
Piccart MJ, Stuart GC, Cassidy J, Bertelsen K, Parmar MK, Eisenhauer EA, Kaye SB, Tropé C, Swenerton K, Harper P, Vermorken JB. Piccart MJ, et al. Among authors: kaye sb. Ann Oncol. 1999;10 Suppl 1:83-6. doi: 10.1023/a:1008371821148. Ann Oncol. 1999. PMID: 10219459
Advanced epithelial ovarian cancer: 1998 consensus statements.
Berek JS, Bertelsen K, du Bois A, Brady MF, Carmichael J, Eisenhauer EA, Gore M, Grenman S, Hamilton TC, Hansen SW, Harper PG, Horvath G, Kaye SB, Lück HJ, Lund B, McGuire WP, Neijt JP, Ozols RF, Parmar MK, Piccart-Gebhart MJ, van Rijswijk R, Rosenberg P, Rustin GJ, Sessa C, Willemse PH, et al. Berek JS, et al. Among authors: kaye sb. Ann Oncol. 1999;10 Suppl 1:87-92. doi: 10.1023/a:1008323922057. Ann Oncol. 1999. PMID: 10219460
[Epithelial ovarian cancer (advanced stage): consensus conference (1998)].
Berek JS, Bertelsen K, du Bois A, Brady MF, Carmichael J, Eisenhauer EA, Gore M, Grenman S, Hamilton TC, Hansen SW, Harper PG, Horvath G, Kaye SB, Lück HJ, Lund B, McGuire WP, Neijt JP, Ozols RF, Parmar MK, Piccart-Gebhart MJ, van Rijswijk R, Rosenberg P, Rustin GJ, Sessa C, Thigpen JT, Tropé C, Tuxen MK, Vergote I, Vermorken JB, Willemse PH. Berek JS, et al. Among authors: kaye sb. Gynecol Obstet Fertil. 2000 Jul-Aug;28(7-8):576-83. Gynecol Obstet Fertil. 2000. PMID: 10996969 Review. French. No abstract available.
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval.
Kaye SB, Colombo N, Monk BJ, Tjulandin S, Kong B, Roy M, Chan S, Filipczyk-Cisarz E, Hagberg H, Vergote I, Lebedinsky C, Parekh T, Santabárbara P, Park YC, Nieto A, Poveda A. Kaye SB, et al. Ann Oncol. 2011 Jan;22(1):49-58. doi: 10.1093/annonc/mdq353. Epub 2010 Jul 19. Ann Oncol. 2011. PMID: 20643863 Free PMC article. Clinical Trial.
1,485 results